| Released | Contributor | Author | Title | Pages | Price |
| 23-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 23-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| Inovio Biomedical | 6 |
$25 |
| 22-Dec-2009 | Reuters Investment Profile |
N/A
| Inovio Biomedical Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 21-Dec-2009 | Wall Street Transcript ,The | The Wall St Transcript | MANAGEMENT TURNOVER REPORT - Inovio Biomedical Corp. (INO) | 8 |
$50 |
| 21-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for INO | 13 |
$25 |
| 19-Dec-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: INOVIO BIOMEDICAL CORP | 5 |
$25 |
| 18-Dec-2009 | Pechala's Reports | Frantisek Pechala | INOVIO BIOMEDICAL CP (INO=US) 12-months forecast | 1 |
$15 |
| 18-Dec-2009 | Pechala's Reports | Lubomir Pechala | INOVIO BIOMEDICAL CP (INO=US) 2-weeks forecast | 1 |
$10 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: INOVIO BIOMEDIC -- INO | 1 |
$4 |
| 17-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACHN , ACEL , BDSI , IMMP , INO -- DRUGS | 3 |
$4 |
0.51% Nasdaq 
0.03 (2.44%) 
Research Reports
